Chimin(SH:603222)2017-04-27 16:00Financial Performance - Operating revenue for the first quarter reached CNY 133,224,729.02, a growth of 29.90% year-on-year[6] - Net profit attributable to shareholders was CNY 8,666,820.20, reflecting a 27.41% increase from the same period last year[6] - Basic earnings per share increased by 50.00% to CNY 0.03[6] - Operating revenue for Q1 2017 reached ¥133,224,729.02, a 29.90% increase compared to ¥102,555,770.22 in the previous period, primarily due to the consolidation of subsidiaries Ezhou Second Hospital and "LINEAR" company[13] - Operating profit for Q1 2017 was CNY 11,496,853.39, compared to CNY 8,367,688.37 in the previous year, representing a growth of 37%[24] - The company reported a total comprehensive income of ¥572,371.11 for Q1 2017, down from ¥1,444,051.31 in the previous year[27] Assets and Liabilities - Total assets increased by 32.09% to CNY 1,218,404,595.45 compared to the end of the previous year[6] - Fixed assets increased by 39.80% to CNY 234,807,641.93 due to the consolidation of subsidiaries[12] - Total liabilities and equity amounted to CNY 1,218,404,595.45, compared to CNY 922,425,299.53, reflecting a year-over-year increase of 32%[21] - Current liabilities totaled CNY 210,701,920.47, significantly higher than CNY 91,641,938.16 at the beginning of the year[20] - Non-current liabilities amounted to CNY 161,891,615.65, compared to CNY 21,843,842.16 at the start of the year, indicating a substantial increase[20] Cash Flow - Cash flow from operating activities showed a net outflow of CNY -9,508,695.20, worsening by 174.43% compared to the previous year[6] - The company reported a net cash outflow from operating activities of ¥9,508,695.20, worsening from a cash outflow of ¥3,464,933.12 in Q1 2016[29] - Cash received from sales of goods and services rose by 37.39% to ¥113,267,939.15, reflecting the impact of the subsidiaries' integration[14] - The cash inflow from operating activities totaled ¥116,906,711.97, compared to ¥86,332,727.08 in Q1 2016, indicating a growth of 35.4%[29] - Total cash outflow from investment activities was CNY 258,993,251.84, significantly higher than CNY 71,534,962.57 in the previous year[33] Shareholder Information - The number of shareholders reached 20,527 by the end of the reporting period[10] - The largest shareholder, Shuangge Group Co., Ltd., holds 36.20% of the shares, with 115,830,800 shares pledged[10] - Minority shareholders' equity increased by 49.10% to ¥86,029,526.94, mainly due to the acquisition of Ezhou Second Hospital[13] Other Financial Metrics - The weighted average return on equity rose by 0.21 percentage points to 1.15%[6] - The company incurred financial expenses of ¥2,457,733.69 in Q1 2017, compared to a financial income of ¥141,225.32 in the same period last year[27] - The company experienced a foreign exchange loss of CNY 12,491.11 during the period[33]